Skip to content

Clinical trials

Phase 3 Gastrointestinal Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 3 Country / region: Japan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20161
20203
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Center Hospital East2
Pfizer2
AstraZeneca1
Epidemiological and Clinical Research Information Network1
GlaxoSmithKline1
Sumitomo Pharma America, Inc.1
Taiho Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms9
Colorectal Neoplasms6
Digestive System Neoplasms5
Gastrointestinal Diseases5
Intestinal Neoplasms5
Digestive System Diseases4
Colonic Diseases3
Intestinal Diseases3
Rectal Diseases3
Colonic Neoplasms2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.